PROpel Trial Efficacy – LYNPARZA® (olaparib) for BRCAm mCRPC
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Cancer Clinical Trial Interpretation Videos - YouTube
PDF) Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation | NEJM
Servizio Bibliotecario d'Ateneo - Biblioteca Polo San Paolo
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation | British Journal of Cancer
Diapositiva 1
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease | NEJM
Fibrosi polmonare idiopatica: su NEJM studio su una nuova terapia, coordinato da Luca Richeldi - Policlinico Universitario A. Gemelli IRCCS
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Informazioni sui farmaci
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM
Genes | Free Full-Text | Personalized Systemic Therapies in Hereditary Cancer Syndromes
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer | NEJM
Daniel Meyerkort on LinkedIn: #exercise #jointreplacement #tkr #diet #prehab
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
NEJM on X: "The POLO trial evaluated the efficacy of maintenance therapy with olaparib in patients with a germline BRCA mutation and metastatic pancreatic adenocarcinoma that had not progressed during first-line platinum-based
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis | NEJM
Monumen-TAL - I dismantle the ASH/ NEJM Talquetamab study | First of the ASH 2022 video series - YouTube
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
David Vivas on X: "🚨SECURE TRIAL now on NEJM! Polypill better than usual care in secondary prevention after MI! Spanish Investigation on top of @escardio 🇪🇸 Congrats Dr Castellano @CNIC_CARDIO and thnks
